https://stock.noler.com/us/stock/interleukin-genetics-inc https://stock.noler.com/us/stock/interleukin-genetics-inc/accounts-payable https://stock.noler.com/us/stock/interleukin-genetics-inc/accounts-payable-and-accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/interleukin-genetics-inc/accounts-receivable https://stock.noler.com/us/stock/interleukin-genetics-inc/accounts-receivable-related-parties-current https://stock.noler.com/us/stock/interleukin-genetics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/interleukin-genetics-inc/accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/interleukin-genetics-inc/accumulated-depreciation https://stock.noler.com/us/stock/interleukin-genetics-inc/acquisition-consideration-transferred https://stock.noler.com/us/stock/interleukin-genetics-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/interleukin-genetics-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/interleukin-genetics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/interleukin-genetics-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/interleukin-genetics-inc/adjustment-for-amortization https://stock.noler.com/us/stock/interleukin-genetics-inc/advertising-expense https://stock.noler.com/us/stock/interleukin-genetics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/interleukin-genetics-inc/amended-reports-10-k https://stock.noler.com/us/stock/interleukin-genetics-inc/amended-reports-10-q https://stock.noler.com/us/stock/interleukin-genetics-inc/amortization https://stock.noler.com/us/stock/interleukin-genetics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/interleukin-genetics-inc/area-of-land https://stock.noler.com/us/stock/interleukin-genetics-inc/assets-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/interleukin-genetics-inc/capital-expenditures https://stock.noler.com/us/stock/interleukin-genetics-inc/capital-leased-assets-gross https://stock.noler.com/us/stock/interleukin-genetics-inc/cash https://stock.noler.com/us/stock/interleukin-genetics-inc/cash-and-equivalents https://stock.noler.com/us/stock/interleukin-genetics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/interleukin-genetics-inc/cash-provided-by-used-in-investing-activities-discontinued-operations https://stock.noler.com/us/stock/interleukin-genetics-inc/cash-provided-by-used-in-operating-activities-discontinued-operations https://stock.noler.com/us/stock/interleukin-genetics-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/interleukin-genetics-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights-1 https://stock.noler.com/us/stock/interleukin-genetics-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/interleukin-genetics-inc/clinical-trials https://stock.noler.com/us/stock/interleukin-genetics-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/interleukin-genetics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/interleukin-genetics-inc/common-stock-value https://stock.noler.com/us/stock/interleukin-genetics-inc/common-stock-value-outstanding https://stock.noler.com/us/stock/interleukin-genetics-inc/concentration-risk-percentage https://stock.noler.com/us/stock/interleukin-genetics-inc/construction-in-progress-gross https://stock.noler.com/us/stock/interleukin-genetics-inc/contracts-revenue https://stock.noler.com/us/stock/interleukin-genetics-inc/conversion-of-stock-amount-issued https://stock.noler.com/us/stock/interleukin-genetics-inc/conversion-of-stock-shares-converted https://stock.noler.com/us/stock/interleukin-genetics-inc/conversion-of-stock-shares-issued https://stock.noler.com/us/stock/interleukin-genetics-inc/convertible-debt https://stock.noler.com/us/stock/interleukin-genetics-inc/convertible-debt-current https://stock.noler.com/us/stock/interleukin-genetics-inc/convertible-debt-fair-value-disclosures https://stock.noler.com/us/stock/interleukin-genetics-inc/convertible-debt-noncurrent https://stock.noler.com/us/stock/interleukin-genetics-inc/cost-of-revenue https://stock.noler.com/us/stock/interleukin-genetics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/interleukin-genetics-inc/current-assets https://stock.noler.com/us/stock/interleukin-genetics-inc/current-liabilities https://stock.noler.com/us/stock/interleukin-genetics-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/interleukin-genetics-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/interleukin-genetics-inc/debt-conversion-converted-instrument-shares-issued https://stock.noler.com/us/stock/interleukin-genetics-inc/debt-conversion-original-debt-amount https://stock.noler.com/us/stock/interleukin-genetics-inc/debt-unamortized-discount https://stock.noler.com/us/stock/interleukin-genetics-inc/deferred-compensation-arrangement-with-individual-cash-awards-granted-percentage https://stock.noler.com/us/stock/interleukin-genetics-inc/deferred-revenue https://stock.noler.com/us/stock/interleukin-genetics-inc/deferred-revenue-2 https://stock.noler.com/us/stock/interleukin-genetics-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/interleukin-genetics-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/interleukin-genetics-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/interleukin-genetics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/interleukin-genetics-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/interleukin-genetics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/interleukin-genetics-inc/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/interleukin-genetics-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/interleukin-genetics-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/interleukin-genetics-inc/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits-employee-compensation https://stock.noler.com/us/stock/interleukin-genetics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/interleukin-genetics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/interleukin-genetics-inc/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/interleukin-genetics-inc/deferred-tax-liabilities-tax-deferred-income https://stock.noler.com/us/stock/interleukin-genetics-inc/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/interleukin-genetics-inc/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/interleukin-genetics-inc/defined-contribution-plan-maximum-annual-contribution-per-employee-amount https://stock.noler.com/us/stock/interleukin-genetics-inc/defined-contribution-plan-maximum-annual-contributions-per-employee-amount https://stock.noler.com/us/stock/interleukin-genetics-inc/depreciation-and-amortization https://stock.noler.com/us/stock/interleukin-genetics-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/interleukin-genetics-inc/disposal-group-including-discontinued-operation-other-current-assets https://stock.noler.com/us/stock/interleukin-genetics-inc/due-from-related-parties-current https://stock.noler.com/us/stock/interleukin-genetics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/interleukin-genetics-inc/employee-benefits-and-share-based-compensation https://stock.noler.com/us/stock/interleukin-genetics-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/interleukin-genetics-inc/employee-stock-ownership-plan-esop-compensation-expense https://stock.noler.com/us/stock/interleukin-genetics-inc/employee-stock-ownership-plan-esop-weighted-average-purchase-price-of-shares-purchased https://stock.noler.com/us/stock/interleukin-genetics-inc/equity-method-investment-ownership-percentage https://stock.noler.com/us/stock/interleukin-genetics-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/interleukin-genetics-inc/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/interleukin-genetics-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/interleukin-genetics-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/interleukin-genetics-inc/financing-cash-flow https://stock.noler.com/us/stock/interleukin-genetics-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/interleukin-genetics-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/interleukin-genetics-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/interleukin-genetics-inc/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/interleukin-genetics-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/interleukin-genetics-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/interleukin-genetics-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/interleukin-genetics-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/interleukin-genetics-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/interleukin-genetics-inc/finite-lived-patents-gross https://stock.noler.com/us/stock/interleukin-genetics-inc/form-d-other https://stock.noler.com/us/stock/interleukin-genetics-inc/form-d-stocks https://stock.noler.com/us/stock/interleukin-genetics-inc/furniture-and-fixtures-gross https://stock.noler.com/us/stock/interleukin-genetics-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/interleukin-genetics-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/interleukin-genetics-inc/grants-receivable-current https://stock.noler.com/us/stock/interleukin-genetics-inc/gross-profit https://stock.noler.com/us/stock/interleukin-genetics-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/interleukin-genetics-inc/income-loss-from https://stock.noler.com/us/stock/interleukin-genetics-inc/income-loss-from-discontinued-operations-net-of-tax https://stock.noler.com/us/stock/interleukin-genetics-inc/income-loss-from-discontinued-operations-net-of-tax-per-basic-and-diluted-share https://stock.noler.com/us/stock/interleukin-genetics-inc/income-loss-from-per-basic-and-diluted-share https://stock.noler.com/us/stock/interleukin-genetics-inc/income-tax https://stock.noler.com/us/stock/interleukin-genetics-inc/income-taxes-paid https://stock.noler.com/us/stock/interleukin-genetics-inc/increase-decrease-in-accounts-and-other-receivables https://stock.noler.com/us/stock/interleukin-genetics-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/interleukin-genetics-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/interleukin-genetics-inc/increase-decrease-in-accounts-receivable-related-parties https://stock.noler.com/us/stock/interleukin-genetics-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/interleukin-genetics-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/interleukin-genetics-inc/increase-decrease-in-derivative-liabilities https://stock.noler.com/us/stock/interleukin-genetics-inc/increase-decrease-in-due-from-related-parties-current https://stock.noler.com/us/stock/interleukin-genetics-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/interleukin-genetics-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/interleukin-genetics-inc/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/interleukin-genetics-inc/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/interleukin-genetics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/interleukin-genetics-inc/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/interleukin-genetics-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/interleukin-genetics-inc/insider-transactions-corporate-securities/purchases https://stock.noler.com/us/stock/interleukin-genetics-inc/insider-transactions-other https://stock.noler.com/us/stock/interleukin-genetics-inc/insider-transactions-preferred https://stock.noler.com/us/stock/interleukin-genetics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/interleukin-genetics-inc/insider-transactions-warrants https://stock.noler.com/us/stock/interleukin-genetics-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/interleukin-genetics-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/interleukin-genetics-inc/interest-expense https://stock.noler.com/us/stock/interleukin-genetics-inc/interest-paid https://stock.noler.com/us/stock/interleukin-genetics-inc/interest-payable-current https://stock.noler.com/us/stock/interleukin-genetics-inc/inventory https://stock.noler.com/us/stock/interleukin-genetics-inc/inventory-finished-goods https://stock.noler.com/us/stock/interleukin-genetics-inc/inventory-raw-materials https://stock.noler.com/us/stock/interleukin-genetics-inc/investing-cash-flow https://stock.noler.com/us/stock/interleukin-genetics-inc/investment-income-interest https://stock.noler.com/us/stock/interleukin-genetics-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/interleukin-genetics-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/interleukin-genetics-inc/lease-and-rental-expense https://stock.noler.com/us/stock/interleukin-genetics-inc/lease-incentive-payable-current-and-noncurrent https://stock.noler.com/us/stock/interleukin-genetics-inc/leasehold-improvements-gross https://stock.noler.com/us/stock/interleukin-genetics-inc/liabilities-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/interleukin-genetics-inc/license-and-services-revenue https://stock.noler.com/us/stock/interleukin-genetics-inc/line-of-credit-facility-amount-outstanding https://stock.noler.com/us/stock/interleukin-genetics-inc/line-of-credit-facility-increase-additional-borrowings https://stock.noler.com/us/stock/interleukin-genetics-inc/long-term-debt https://stock.noler.com/us/stock/interleukin-genetics-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/interleukin-genetics-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/interleukin-genetics-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/interleukin-genetics-inc/net-change-in-cash https://stock.noler.com/us/stock/interleukin-genetics-inc/net-income https://stock.noler.com/us/stock/interleukin-genetics-inc/notes-payable-current https://stock.noler.com/us/stock/interleukin-genetics-inc/officers-compensation https://stock.noler.com/us/stock/interleukin-genetics-inc/operating-cash-flow https://stock.noler.com/us/stock/interleukin-genetics-inc/operating-expenses https://stock.noler.com/us/stock/interleukin-genetics-inc/operating-income https://stock.noler.com/us/stock/interleukin-genetics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/interleukin-genetics-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/interleukin-genetics-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/interleukin-genetics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/interleukin-genetics-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/interleukin-genetics-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/interleukin-genetics-inc/other-accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/interleukin-genetics-inc/other-assets https://stock.noler.com/us/stock/interleukin-genetics-inc/other-current-assets https://stock.noler.com/us/stock/interleukin-genetics-inc/other-income https://stock.noler.com/us/stock/interleukin-genetics-inc/other-income-2 https://stock.noler.com/us/stock/interleukin-genetics-inc/other-noncash-expense https://stock.noler.com/us/stock/interleukin-genetics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/interleukin-genetics-inc/other-nonoperating-income https://stock.noler.com/us/stock/interleukin-genetics-inc/other-sales-revenue-net https://stock.noler.com/us/stock/interleukin-genetics-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/interleukin-genetics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/interleukin-genetics-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/interleukin-genetics-inc/paid-in-kind-interest https://stock.noler.com/us/stock/interleukin-genetics-inc/payments-for-commissions https://stock.noler.com/us/stock/interleukin-genetics-inc/payments-of-debt-restructuring-costs https://stock.noler.com/us/stock/interleukin-genetics-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/interleukin-genetics-inc/preferred-shares-facts https://stock.noler.com/us/stock/interleukin-genetics-inc/preferred-stock-dividend-rate-percentage https://stock.noler.com/us/stock/interleukin-genetics-inc/preferred-stock-liquidation-preference-value https://stock.noler.com/us/stock/interleukin-genetics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/interleukin-genetics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/interleukin-genetics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/interleukin-genetics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/interleukin-genetics-inc/preferred-stock-value https://stock.noler.com/us/stock/interleukin-genetics-inc/prepaid-expense-current https://stock.noler.com/us/stock/interleukin-genetics-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/interleukin-genetics-inc/proceeds-from-contributions-from-affiliates https://stock.noler.com/us/stock/interleukin-genetics-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/interleukin-genetics-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/interleukin-genetics-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans https://stock.noler.com/us/stock/interleukin-genetics-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans-including-stock-options https://stock.noler.com/us/stock/interleukin-genetics-inc/proceeds-from-license-fees-received https://stock.noler.com/us/stock/interleukin-genetics-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/interleukin-genetics-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/interleukin-genetics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/interleukin-genetics-inc/property-plant-and-equipment-disposals https://stock.noler.com/us/stock/interleukin-genetics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/interleukin-genetics-inc/property-plant-equipment https://stock.noler.com/us/stock/interleukin-genetics-inc/public-float https://stock.noler.com/us/stock/interleukin-genetics-inc/recovery-of-direct-costs https://stock.noler.com/us/stock/interleukin-genetics-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/interleukin-genetics-inc/research-and-development https://stock.noler.com/us/stock/interleukin-genetics-inc/retained-earnings https://stock.noler.com/us/stock/interleukin-genetics-inc/revenue https://stock.noler.com/us/stock/interleukin-genetics-inc/revenue-recognition-milestone-method-revenue-recognized https://stock.noler.com/us/stock/interleukin-genetics-inc/revenue-recognition-sales-returns-reserve-for-sales-returns https://stock.noler.com/us/stock/interleukin-genetics-inc/salaries-wages-and-officers-compensation https://stock.noler.com/us/stock/interleukin-genetics-inc/sales-commissions-and-fees https://stock.noler.com/us/stock/interleukin-genetics-inc/sales-revenue-net https://stock.noler.com/us/stock/interleukin-genetics-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/interleukin-genetics-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/interleukin-genetics-inc/sec-filings-10-k https://stock.noler.com/us/stock/interleukin-genetics-inc/sec-filings-10-q https://stock.noler.com/us/stock/interleukin-genetics-inc/sec-filings-10ksb https://stock.noler.com/us/stock/interleukin-genetics-inc/sec-filings-10qsb https://stock.noler.com/us/stock/interleukin-genetics-inc/sec-filings-15-12b https://stock.noler.com/us/stock/interleukin-genetics-inc/sec-filings-25 https://stock.noler.com/us/stock/interleukin-genetics-inc/sec-filings-25-nse https://stock.noler.com/us/stock/interleukin-genetics-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/interleukin-genetics-inc/sec-filings-8-a12g https://stock.noler.com/us/stock/interleukin-genetics-inc/sec-filings-8-k https://stock.noler.com/us/stock/interleukin-genetics-inc/sec-filings-ars https://stock.noler.com/us/stock/interleukin-genetics-inc/sec-filings-certamx https://stock.noler.com/us/stock/interleukin-genetics-inc/sec-filings-ct-order https://stock.noler.com/us/stock/interleukin-genetics-inc/sec-filings-def-14a https://stock.noler.com/us/stock/interleukin-genetics-inc/sec-filings-defa14a https://stock.noler.com/us/stock/interleukin-genetics-inc/sec-filings-defr14a https://stock.noler.com/us/stock/interleukin-genetics-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/interleukin-genetics-inc/sec-filings-prer14a https://stock.noler.com/us/stock/interleukin-genetics-inc/sec-filings-regdex https://stock.noler.com/us/stock/interleukin-genetics-inc/sec-filings-sb-2 https://stock.noler.com/us/stock/interleukin-genetics-inc/sec-filings-sc-14f1 https://stock.noler.com/us/stock/interleukin-genetics-inc/secondary-offerings-form-424b2 https://stock.noler.com/us/stock/interleukin-genetics-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/interleukin-genetics-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/interleukin-genetics-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/interleukin-genetics-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/interleukin-genetics-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/interleukin-genetics-inc/secondary-offerings-form-rw https://stock.noler.com/us/stock/interleukin-genetics-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/interleukin-genetics-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/interleukin-genetics-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/interleukin-genetics-inc/sga-expense https://stock.noler.com/us/stock/interleukin-genetics-inc/share-price https://stock.noler.com/us/stock/interleukin-genetics-inc/shareholders-equity https://stock.noler.com/us/stock/interleukin-genetics-inc/shares-authorized https://stock.noler.com/us/stock/interleukin-genetics-inc/shares-issued https://stock.noler.com/us/stock/interleukin-genetics-inc/short-term-borrowings https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-award-accelerated-compensation-cost https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-award-award-vesting-rights-percentage https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-award-purchase-price-of-common-stock-percent https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-based-compensation https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-compensation-unrecognized-cost-share-based-awards-other-than-options https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-issued-shares-issued-shares-espps https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-issued-shares-issued-value-employee-stock-ownership-plan https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-issued-shares-issued-value-restricted-stock-award-forfeitures https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-options-grants-in-period-grant-date-intrinsic-value https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/interleukin-genetics-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/interleukin-genetics-inc/tax-credit-carryforward-deferred-tax-asset https://stock.noler.com/us/stock/interleukin-genetics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/interleukin-genetics-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/interleukin-genetics-inc/tax-rate-reconciliation-equity-in-earnings-losses-of-unconsolidated-subsidiary https://stock.noler.com/us/stock/interleukin-genetics-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/interleukin-genetics-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/interleukin-genetics-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/interleukin-genetics-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/interleukin-genetics-inc/tax-rate-reconciliation-tax-settlements https://stock.noler.com/us/stock/interleukin-genetics-inc/total-assets https://stock.noler.com/us/stock/interleukin-genetics-inc/total-liabilities https://stock.noler.com/us/stock/interleukin-genetics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/interleukin-genetics-inc/travel-and-entertainment-expense https://stock.noler.com/us/stock/interleukin-genetics-inc/utilities-operating-expense-depreciation-and-amortization https://stock.noler.com/us/stock/interleukin-genetics-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/interleukin-genetics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/interleukin-genetics-inc/weighted-average-number-of-shares-restricted-stock